Global Biomarkers Market to reach USD 92.2 billion by 2026. 

Global Biomarkers Market Size study, by Application (Diagnosis, Drug Discovery and Development, Others), Product (Biomarker Test Kits, Biomarker Analyzers), End Use (Hospitals, Research laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories), Disease Indication (Cancer, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder, Others) and Regional Forecasts 2019-2026 
Product Code:  HALB_93933422
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Biomarkers Market, by Application, 2016-2026 (USD Billion)
1.3.2.	Biomarkers Market, by Product, 2016-2026 (USD Billion)
1.3.3.	Biomarkers Market, by End Use, 2016-2026 (USD Billion)
1.3.4.	Biomarkers Market, by Disease Indication, 2016-2026 (USD Billion)
1.3.5.	Biomarkers Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Biomarkers Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Biomarkers Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Biomarkers Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Biomarkers Market, by Application
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Biomarkers Market, Sub Segment Analysis
5.3.1.	 Diagnosis    
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	 Drug Discovery and Development
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.	 Others
5.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Biomarkers Market, by Product          
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Biomarkers Market, Sub Segment Analysis
6.3.1.	 Biomarker Test Kits   
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	 Biomarker Analyzers
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7.	Global Biomarkers Market, by End Use        
7.1.	Market Snapshot 
7.2.	Market Performance - Potential Model
7.3.	Biomarkers Market, Sub Segment Analysis
7.3.1.	 Hospitals
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.	 Research laboratories
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.	Ambulatory Surgical Centers
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.	Diagnostic Laboratories
7.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8.	Global Biomarkers Market, by Disease Indication        
8.1.	Market Snapshot 
8.2.	Market Performance - Potential Model
8.3.	Biomarkers Market, Sub Segment Analysis
8.3.1.	Cancer
8.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.	Cardiovascular Diseases
8.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.	Infectious Disease
8.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.4.	Neurological Disorder
8.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.5.	Immunological Disorder
8.3.5.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.5.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.6.	Others
8.3.6.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.6.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9.	Global Biomarkers Market, by Regional Analysis
9.1.	Biomarkers Market, Regional Market Snapshot (2016-2026)
9.2.	North America Biomarkers Market Snapshot
9.2.1.	U.S.
9.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.1.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.1.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.1.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.	Canada
9.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.2.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.2.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.2.2.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)   
9.3.	Europe Biomarkers Market Snapshot
9.3.1.	U.K. 
9.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.1.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.1.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.1.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)  
9.3.2.	Rest of Europe
9.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.2.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.2.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.3.2.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)   
9.4.	Asia Biomarkers Market Snapshot
9.4.1.	China 
9.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.1.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.1.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.1.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)  
9.4.2.	India 
9.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.2.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.2.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.2.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)   
9.4.3.	Japan
9.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.3.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.3.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.3.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)  
9.4.4.	Rest of Asia Pacific
9.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.4.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.4.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.4.4.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)   
9.5.	Latin America Biomarkers Market Snapshot
9.5.1.	Brazil 
9.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.1.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.1.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.1.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)  

9.5.2.	Mexico 
9.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.2.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.2.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.5.2.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.6.	Rest of The World 
9.6.1.	Middle East and Africa
9.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.2.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.6.1.3.	Product breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.6.1.4.	End Use breakdown estimates & forecasts, 2016-2026 (USD Billion) 
9.6.1.5.	 Disease Infection breakdown estimates & forecasts, 2016-2026 (USD Billion)  
Chapter 10.	Competitive Intelligence
10.1.	Company Market Share (Subject to Data Availability)
10.2.	Top Market Strategies
10.3.	Company Profiles
10.3.1.	 Abbott Laboratories
10.3.1.1.	Overview
10.3.1.2.	Financial (Subject to Data Availability)
10.3.1.3.	Product Summary
10.3.1.4.	Recent Developments
10.3.2.	  Medtronic
10.3.3.	 BG Medicine, Inc
10.3.4.	 Qiagen NV
10.3.5.	 Nexus_DX
10.3.6.	 Lifesign LLC
10.3.7.	 Hoffman LA Roche Ltd
10.3.8.	 Siemens Healthnineers
Chapter 11.	Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.1.6.	Research Assumption

List of Tables
TABLE 1.	LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOMARKERS MARKET
TABLE 2.	LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOMARKERS MARKET
TABLE 3.	GLOBAL BIOMARKERS MARKET, REPORT SCOPE
TABLE 4.	YEARS CONSIDERED FOR THE STUDY
TABLE 5.	EXCHANGE RATES CONSIDERED
TABLE 6.	GLOBAL BIOMARKERS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7.	GLOBAL BIOMARKERS MARKET ESTIMATES & FORECASTS BY SERVICE 2016-2026 (USD BILLION)
TABLE 8.	GLOBAL BIOMARKERS MARKET ESTIMATES & FORECASTS BY OWNERSHIP 2016-2026 (USD BILLION)
TABLE 9.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 17.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 19.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 21.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 23.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 25.	GLOBAL BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26.	GLOBAL BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 27.	U.S. BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28.	U.S. BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29.	U.S. BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30.	CANADA BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31.	CANADA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32.	CANADA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33.	UK BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34.	UK BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35.	UK BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36.	GERMANY BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37.	GERMANY BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38.	GERMANY BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39.	ROE BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40.	ROE BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41.	ROE BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42.	CHINA BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43.	CHINA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44.	CHINA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45.	INDIA BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46.	INDIA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47.	INDIA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48.	JAPAN BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49.	JAPAN BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50.	JAPAN BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51.	ROAPAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52.	ROAPAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53.	ROAPAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54.	BRAZIL BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55.	BRAZIL BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56.	BRAZIL BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57.	MEXICO BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58.	MEXICO BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59.	MEXICO BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60.	ROLA BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 61.	ROLA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62.	ROLA BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63.	ROW BIOMARKERS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 64.	ROW BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65.	ROW BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures
FIG 1.	GLOBAL BIOMARKERS MARKET, RESEARCH METHODOLOGY
FIG 2.	GLOBAL BIOMARKERS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3.	GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4.	GLOBAL BIOMARKERS MARKET, KEY TRENDS 2017
FIG 5.	GLOBAL BIOMARKERS MARKET, GROWTH PROSPECTS 2018-2026
FIG 6.	GLOBAL BIOMARKERS MARKET, PORTERS 5 FORCE MODEL
FIG 7.	GLOBAL BIOMARKERS MARKET, PEST ANALYSIS
FIG 8.	GLOBAL BIOMARKERS MARKET, VALUE CHAIN ANALYSIS
FIG 9.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17.	GLOBAL BIOMARKERS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18.	GLOBAL BIOMARKERS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 19.	NORTH AMERICA BIOMARKERS MARKET 2016 & 2026 (USD BILLION)
FIG 20.	EUROPE BIOMARKERS MARKET 2016 & 2026 (USD BILLION)
FIG 21.	ASIA PACIFIC BIOMARKERS MARKET 2016 & 2026 (USD BILLION)
FIG 22.	LATIN AMERICA BIOMARKERS MARKET 2016 & 2026 (USD BILLION)
FIG 23.	GLOBAL BIOMARKERS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)















Global Biomarkers Market is valued approximately USD 33.5 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2019-2026. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world. Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe.

The regional analysis of global Biomarkers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of urgent care services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as surging research & development funding for biotech and pharma organizations, escalating number of CROs and improving low cost for clinical trials would create lucrative growth prospects for the Biomarkers market across Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Medtronic
BG Medicine, Inc
Siemens Healthnineers
Nexus-DX
Qiagen N.V
Lifesign LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Diagnosis
Drug Discovery and Development
Others
By Product:

Biomarker Test Kits
Biomarker Analyzers
By End Use:

Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
By Disease Indication:

Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Biomarkers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…